PT - JOURNAL ARTICLE AU - Erster, Oran AU - Shkedi, Omer AU - Benedek, Gil AU - Zilber, Eyal AU - Varkovitzky, Itay AU - Shirazi, Rachel AU - Shorka, Dorit Oriya AU - Cohen, Yuval AU - Bar, Tzahi AU - Yechieli, Rafi AU - Oikawa, Michal Tepperberg AU - Venkert, Dana AU - Linial, Michal AU - Oiknine-Djian, Esther AU - Mandelboim, Michal AU - Livneh, Zvi AU - Shenhav-Saltzman, Gilat AU - Mendelson, Ella AU - Wolf, Dana AU - Szwarcwort-Cohen, Moran AU - Mor, Orna AU - Lewis, Yair AU - Zeevi, Danny TI - Improved Sensitivity, Safety, and Rapidity of COVID-19 Tests by Replacing Viral Storage Solution with Lysis Buffer AID - 10.1101/2020.09.25.20201921 DP - 2020 Jan 01 TA - medRxiv PG - 2020.09.25.20201921 4099 - http://medrxiv.org/content/early/2020/10/04/2020.09.25.20201921.short 4100 - http://medrxiv.org/content/early/2020/10/04/2020.09.25.20201921.full AB - Conducting numerous, rapid, and reliable PCR tests for SARS-CoV-2 is essential for our ability to monitor and control the current COVID-19 pandemic.Here, we tested the sensitivity and efficiency of SARS-CoV-2 detection in clinical samples collected directly into a mix of lysis buffer and RNA preservative, thus inactivating the virus immediately after sampling.We tested 79 COVID-19 patients and 20 healthy controls. We collected two samples (nasopharyngeal swabs) from each participant: one swab was inserted into a test tube with Viral Transport Medium (VTM), following the standard guideline used as the recommended method for sample collection; the other swab was inserted into a lysis buffer supplemented with nucleic acid stabilization mix (coined NSLB).We found that RT-qPCR tests of patients were significantly more sensitive with NSLB sampling, reaching detection threshold 2.1±0.6 (Mean±SE) PCR cycles earlier then VTM samples from the same patient. We show that this improvement is most likely since NSLB samples are not diluted in lysis buffer before RNA extraction. Re-extracting RNA from NSLB samples after 72 hours at room temperature did not affect the sensitivity of detection, demonstrating that NSLB allows for long periods of sample preservation without special cooling equipment. We also show that swirling the swab in NSLB and discarding it did not reduce sensitivity compared to retaining the swab in the tube, thus allowing improved automation of COVID-19 tests. Overall, we show that using NSLB instead of VTM can improve the sensitivity, safety, and rapidity of COVID-19 tests at a time most needed.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRBs of the Sheba, Hadassah, and Rambam Medical Centers in Israel have approved this research.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the raw data is available in the Supplementary Material.